MRI manifestions correlate with survival of glioblastoma multiforme patients

Wen-Bin Li1, Kai Tang, Qian Chen

  • 1Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.

Abstract

Insights

Magnetic resonance imaging (MRI) features like tumor enhancement, edema, and T2-weighted intensity correlate with glioblastoma multiforme (GBM) patient survival. These findings can help predict prognosis for GBM patients.

Area of Science:

  • Neuro-oncology
  • Radiology
  • Medical Imaging

Background:

  • Glioblastoma multiforme (GBM) is an aggressive brain tumor with a poor prognosis.
  • Accurate prognostic indicators are crucial for guiding treatment strategies and patient management.

Purpose of the Study:

  • To investigate the correlation between specific magnetic resonance imaging (MRI) features and the overall survival (OS) of patients diagnosed with GBM.

Main Methods:

  • Retrospective analysis of MRI scans from 30 GBM patients.
  • Evaluation of imaging features: contrasted enhancement area, peritumoral edema, and T2-weighted signal intensity.
  • Statistical analysis using SPSS 19.0, including Kaplan-Meier survival analysis and log-rank tests.

Main Results:

  • Limited contrasted enhancement (≤5%) was associated with longer OS.
  • Absence of peritumoral edema correlated with improved OS.
  • Tumors with hyperintensity and/or isointensity on T2-weighted imaging showed longer OS compared to those with hypointensity.

Conclusions:

  • Certain MRI features, including contrasted enhancement extent, edema presence, and T2-weighted signal intensity, are significant prognostic indicators for GBM patients.
  • These imaging biomarkers can aid in predicting survival outcomes and informing clinical decision-making for GBM.